Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial.

Korobelnik J-F., Leal S., Lanzetta P., PULSAR study investigators .

DOI

10.1038/s41433-026-04486-1

Type

Journal article

Publication Date

2026-05-01T00:00:00+00:00

Addresses

CHU Bordeaux, Service d'Ophtalmologie, Bordeaux, France. jean-francois.korobelnik@chu-bordeaux.fr.

Keywords

PULSAR study investigators

Permalink More information Close